|
市場調査レポート
商品コード
1672074
新生児スクリーニングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）Global Newborn Screening Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033 |
||||||
カスタマイズ可能
|
|||||||
| 新生児スクリーニングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年） |
|
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
世界の新生児スクリーニングの市場規模は、2024年の9億5,614万米ドルから2033年には19億3,857万米ドルに成長し、2026年～2033年の予測期間中に8.17％の堅調なCAGRを示すと予測されます。
新生児スクリーニング市場は、先天性疾患や代謝性疾患の早期発見の重要性に対する意識の高まりに後押しされ、大きな成長を遂げています。医療提供者が予防医療と早期介入を優先するにつれて、包括的な新生児スクリーニングプログラムの需要が急増しています。タンデム質量分析計や遺伝子検査などの治療技術の進歩により、幅広い疾患のスクリーニング能力が強化され、タイムリーな診断と治療が可能となっています。この動向は、健康状態の改善における新生児スクリーニングの重要な役割を親と医療専門家が同様に認識していることから、市場を前進させると予想されます。
スクリーニング手法と技術の革新が新生児スクリーニング市場の将来を形成しています。非侵襲的検査法とポイントオブケア検査ソリューションの開発により、家族にとってのアクセシビリティと利便性が向上し、迅速な結果とフォローアップケアが可能になりつつあります。さらに、データ管理と遠隔医療ソリューションの進歩により、スクリーニングプロセスが合理化され、医療提供者と家族の間のより良いコミュニケーションが促進されています。新生児スクリーニングで検出できる新たな疾患の発見が研究で進むにつれて、市場は新たな疾患を含むスクリーニングパネルの拡大を経験する可能性が高くなっています。
さらに、新生児スクリーニング市場は、スクリーニングプログラムの強化を目的とした公衆衛生イニシアティブや規制支援への投資の増加から恩恵を受けると思われます。医療提供者、政策立案者、アドボカシーグループ間の協力的な取り組みは、包括的な新生児スクリーニングサービスへの認識を促進し、アクセスを確保する上で不可欠です。情勢が進展するにつれ、新生児スクリーニングをより広範な母子保健戦略に統合する方向にますます焦点が移行し、新生児の最適な健康アウトカムを達成するための教育、フォローアップケア、継続的支援の重要性が強調されるようになると思われます。
当社のレポートは、さまざまな業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために、綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：
市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。
市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。
セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。
競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。
市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。
地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。
新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 新生児スクリーニングの産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーリスト
- マーケティングチャネル
- ダイレクトマーケティング
- インダイレクトマーケティング
- マーケティングチャネル発展動向
第5章 新生児スクリーニングの世界市場分析：製品別
- 製品別の概要
- 製品別の実績・予測データ分析
- 検査機器
- 試薬
第6章 新生児スクリーニングの世界市場分析：技術別
- 技術別の概要
- 技術別の実績・予測データ分析
- タンデム質量分析
- パルスオキシメトリー
- 酵素ベースアッセイ
- DNAアッセイ
- 電気泳動
- その他
第7章 新生児スクリーニングの世界市場分析：検査タイプ別
- 検査タイプ別の概要
- 検査タイプ別の実績・予測データ分析
- 乾燥血液スポット検査
- CCHD
- 聴力検査
第8章 新生児スクリーニングの世界市場分析：地域別
- 地域別の展望
- イントロダクション
- 北米の売上分析
- 概要・実績・予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州の売上分析
- 概要・実績・予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他欧州
- アジア太平洋の売上分析
- 概要・実績・予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他アジア太平洋
- ラテンアメリカの売上分析
- 概要・実績・予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他ラテンアメリカ
- 中東・アフリカの売上分析
- 概要・実績・予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
第9章 新生児スクリーニング企業の競合情勢
- 新生児スクリーニング市場の競合
- 提携・協力・協定
- 合併・買収
- 新製品発売
- その他の開発
第10章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Bio-Rad Laboratories
- Agilent Technologies
- Covidien Plc
- Masimo
- Waters Corporation
- Natus Medical
- Trivitron Healthcare
- GE Lifesciences
- PerkinElmer Inc
- AB SCIEX
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product (USD MN)
- Instruments Market Sales By Geography (USD MN)
- Reagents Market Sales By Geography (USD MN)
- Analysis By Technology (USD MN)
- Tandem Mass Spectrometry Market Sales By Geography (USD MN)
- Pulse Oximetry Market Sales By Geography (USD MN)
- Enzyme Based Assay Market Sales By Geography (USD MN)
- DNA Assay Market Sales By Geography (USD MN)
- Electrophoresis Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By Test Type Outlook (USD MN)
- Dry Blood Spot Test Market Sales By Geography (USD MN)
- CCHD Market Sales By Geography (USD MN)
- Hearing Screen Market Sales By Geography (USD MN)
- Global Newborn Screening Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Newborn Screening Report
- Market Research Process
- Market Research Methodology
- Global Newborn Screening Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product
- Market Attractiveness Analysis By Technology
- Market Attractiveness Analysis By Test Type Outlook
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product (USD MN)
- Instruments Market Sales By Geography (USD MN)
- Reagents Market Sales By Geography (USD MN)
- Global Market Analysis By Technology (USD MN)
- Tandem Mass Spectrometry Market Sales By Geography (USD MN)
- Pulse Oximetry Market Sales By Geography (USD MN)
- Enzyme Based Assay Market Sales By Geography (USD MN)
- DNA Assay Market Sales By Geography (USD MN)
- Electrophoresis Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By Test Type Outlook (USD MN)
- Dry Blood Spot Test Market Sales By Geography (USD MN)
- CCHD Market Sales By Geography (USD MN)
- Hearing Screen Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
- Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Global Newborn Screening Market size is anticipated to grow from USD 956.14 Million in 2024 to USD 1938.57 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.17% during the forecast period of 2026 to 2033.
The newborn screening market is experiencing significant growth, driven by the increasing awareness of the importance of early detection of congenital disorders and metabolic diseases. As healthcare providers prioritize preventive care and early intervention, the demand for comprehensive newborn screening programs is surging. Advances in technology, such as tandem mass spectrometry and genetic testing, are enhancing the ability to screen for a wide range of conditions, enabling timely diagnosis and treatment. This trend is expected to propel the market forward, as parents and healthcare professionals alike recognize the critical role of newborn screening in improving health outcomes.
Innovations in screening methodologies and technologies are shaping the future of the newborn screening market. The development of non-invasive testing methods and point-of-care testing solutions is improving accessibility and convenience for families, allowing for quicker results and follow-up care. Additionally, advancements in data management and telehealth solutions are streamlining the screening process, facilitating better communication between healthcare providers and families. As research continues to uncover new conditions that can be detected through newborn screening, the market is likely to witness the expansion of screening panels to include additional disorders.
Moreover, the newborn screening market will benefit from increased investment in public health initiatives and regulatory support aimed at enhancing screening programs. Collaborative efforts between healthcare providers, policymakers, and advocacy groups will be essential in promoting awareness and ensuring access to comprehensive newborn screening services. As the landscape evolves, the focus will increasingly shift towards integrating newborn screening into broader maternal and child health strategies, emphasizing the importance of education, follow-up care, and ongoing support in achieving optimal health outcomes for newborns.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Product
- Instruments
- Reagents
By Technology
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme Based Assay
- DNA Assay
- Electrophoresis
- Others
By Test Type Outlook
- Dry Blood Spot Test
- CCHD
- Hearing Screen
- COMPANIES PROFILED
- Bio-Rad Laboratories
- Agilent Technologies
- Covidien plc
- Masimo
- Waters Corporation
- Natus Medical
- Trivitron Healthcare
- GE Lifesciences
- PerkinElmer Inc
- AB SCIEX
- The above list can be customized.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. NEWBORN SCREENING INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porters Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Test Type Outlook
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY PRODUCT
- 5.1. Overview By Product
- 5.2. Historical and Forecast Data Analysis By Product
- 5.3. Instruments Historic and Forecast Sales By Regions
- 5.4. Reagents Historic and Forecast Sales By Regions
6. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY TECHNOLOGY
- 6.1. Overview By Technology
- 6.2. Historical and Forecast Data Analysis By Technology
- 6.3. Tandem Mass Spectrometry Historic and Forecast Sales By Regions
- 6.4. Pulse Oximetry Historic and Forecast Sales By Regions
- 6.5. Enzyme Based Assay Historic and Forecast Sales By Regions
- 6.6. DNA Assay Historic and Forecast Sales By Regions
- 6.7. Electrophoresis Historic and Forecast Sales By Regions
- 6.8. Others Historic and Forecast Sales By Regions
7. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY TEST TYPE OUTLOOK
- 7.1. Overview By Test Type Outlook
- 7.2. Historical and Forecast Data Analysis By Test Type Outlook
- 7.3. Dry Blood Spot Test Historic and Forecast Sales By Regions
- 7.4. CCHD Historic and Forecast Sales By Regions
- 7.5. Hearing Screen Historic and Forecast Sales By Regions
8. GLOBAL NEWBORN SCREENING MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE NEWBORN SCREENING COMPANIES
- 9.1. Newborn Screening Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF NEWBORN SCREENING INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Bio-Rad Laboratories
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Agilent Technologies
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Covidien Plc
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Masimo
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Waters Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Natus Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Trivitron Healthcare
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. GE Lifesciences
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. PerkinElmer Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. AB SCIEX
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
